Hengrui Pharma: SHR-2173 injection was approved for clinical trial. Hengrui Pharma announced that its subsidiary, Guangdong Hengrui Pharma Co., Ltd., received the Notice of Approval for Clinical Trial of SHR-2173 injection approved and issued by National Medical Products Administration, and agreed to carry out clinical trial. The indication is lupus nephritis. SHR-2173 injection is a therapeutic biological product independently developed by the company, and the research and development expenses have been invested about 45.03 million yuan. The period from research and development to listing of drugs is long, there are many links, and there are uncertain factors. The company will actively promote research and development projects and fulfill its information disclosure obligations.Puli Pharmaceutical Co., Ltd.: It won the bid for the tenth batch of national centralized drug procurement. According to Puli Pharmaceutical, on December 12, Puli Pharmaceutical's meglumine gadolinium tetate injection (trade name: Puli Yingxian) and Posaconazole injection (trade name: Puli Posa) both won the bid for the tenth batch of national centralized drug procurement.Yingli shares: Yingli shares increased capital by 80 million yuan to its holding subsidiary. Yingli shares announced that the company and Shanghai Moqin Intelligent Technology Co., Ltd. increased capital to Nanchang Yingli Precision Manufacturing Co., Ltd., with a total capital increase of 80 million yuan, of which Yingli shares increased capital by 67 million yuan in cash and Shanghai Moqin increased capital by 13 million yuan in cash. After this capital increase, the registered capital of Nanchang Yingli will increase from 20 million yuan to 100 million yuan. After the capital increase is completed, Yingli shares hold 80% of the shares of Nanchang Yingli and Shanghai Moqin holds 20% of the shares. This capital increase does not constitute a connected transaction and does not need to be submitted to the company's shareholders' meeting for consideration.
Shen Wanhongyuan: "Vigorously boosting consumption" is the first task of economic work next year. The Central Economic Work Conference was held in Beijing from December 11th to 12th. Shen Wanhongyuan released a research opinion saying that in this Central Economic Work Conference, it can be seen that boosting consumption has once again become the top priority in 2025. The "two innovations" and "two heavyweights" in 2024 are important points of economic work. "Two Innovations" means to promote a new round of large-scale equipment renewal and trade-in of consumer goods, and "Two Innovations" means to implement major national strategies and build safety capacity in key areas, and continue to pay attention to the efforts of fiscal policies including extra-long special national debt in this field.The organization looks forward to the semiconductor industry in 2025: the AI replacement tide leads the growth, and the semiconductor ETF(512480) may usher in new development opportunities. On December 13, the semiconductor ETF(512480) closed down by 1.38%, with a turnover of 1.671 billion yuan. The constituent stocks are mixed, and Zhaoyi Innovation leads the rise. In terms of decline, SMIC led the decline. CICC said that after the boom in 2024, it is expected that the inventory of the semiconductor industry will stabilize and the relationship between supply and demand will be more balanced in 2025. With the gradual landing of AI cloud and end demand, domestic semiconductor elements will usher in new development opportunities. In addition, the AI-changing tide has a pulling effect on the downstream demand of the semiconductor design sector, which is expected to accelerate the growth of the semiconductor design sector in 2025 and inject new vitality into the industry.Centaline Property: The price of second-hand houses in Hong Kong dropped by 0.6% on a weekly basis. Centaline Property said on its website that in the week from December 2 to 8, the leading index of Central Plains cities, which measures the price of second-hand houses in Hong Kong, fell by 0.6% to 137.59.
The public security organs that cracked down on the rectification of the "money-changing party" found that the funds involved were more than 80 billion yuan. It was learned from the press conference of the Ministry of Public Security that in May this year, the Ministry of Public Security deployed a special work to crack down on the rectification of the "money-changing party" and derivative crimes. Since the special action, it has been found that the funds involved have flowed more than 80 billion yuan. (Xinhua News Agency)Citigroup: Raise the target price of Autozone from $3,500 to $3,900, and maintain the "buy" rating.Some deposit interest rates have returned to the "2% era". At the end of the year, some small and medium-sized banks "saved money" with high interest rates. Near the end of the year, under the general environment of lowering the RRR and reducing the interest margin, many small and medium-sized banks "bucked the trend", or raised the deposit interest rate and raised interest rates to save money, or launched high-interest deposit products. According to the incomplete statistics of the announcements issued by banks, more than ten small and medium-sized banks have announced to raise deposit interest rates or launch high-interest deposit products. The reporter found out that the phenomenon that some small and medium-sized banks attract customers' deposits at high interest rates does not exist only at the end of the year. In the second half of this year, "high interest rates" are an important "selling point" of their deposit products. (21 Finance)
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14